Croma
Saypha® Filler Lidocaine 1 ml
For licensed healthcare professionals
Shipping calculated at checkout.
Orders are placed through your Renellence representative.
Contact us to orderNew to Renellence? Become a customer
- Authorized Canadian distributor
- Ships to all provinces and territories
- Clinical support from the Renellence team
Health Canada Approved (Licence #98900)
A cross-linked hyaluronic acid filler with 0.3% lidocaine for enhanced comfort. Designed for injection into the mid to deep dermis to correct light to moderate nasolabial folds.
Key Benefits
- High HA concentration (23 mg/mL) with advanced crosslinking
- Proven results up to 9 months post-treatment
- Includes 2 x 27G ½” Terumo™ needles
Indications (Canada)
saypha® filler Lidocaine is indicated for intradermal injection into the mid to deep dermis for correction of light to moderate nasolabial folds.
Product Specifications
| HA Concentration | 23 mg/mL |
| Lidocaine | 0.3% |
| Crosslinking Agent | BDDE (≤2 ppm) |
| Injection Depth | Mid to deep dermis |
| Syringe Volume | 1.0 mL |
| Sterilization | Steam sterilized |
Clinical Highlights
-
93% satisfaction rate at 9 months
- Low extrusion force and optimal viscosity for practitioner control
*This product is intended for use by licensed healthcare professionals only. Always refer to the official IFU prior to use.
At a glance
Saypha® Filler · Refine
- Indicated for
- Light to moderate nasolabial folds
- Injection depth
- Mid to deep dermis
- HA concentration
- 23 mg/mL
- Lidocaine
- 0.3%
- Results
- Up to 9 months
- Clinical highlight
- 93% satisfaction at 9 months
Health Canada licence #98900
See the treatment map →
